SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001193125-19-194786
Filing Date
2019-07-16
Accepted
2019-07-16 16:20:27
Documents
7

Document Format Files

Seq Description Document Type Size
1 F-3 d772608df3.htm F-3 379658
2 EX-5.1 d772608dex51.htm EX-5.1 8533
3 EX-23.1 d772608dex231.htm EX-23.1 6455
4 GRAPHIC g772608g0711082631486.jpg GRAPHIC 3044
5 GRAPHIC g772608g14w32.jpg GRAPHIC 33233
6 GRAPHIC g772608g36k82.jpg GRAPHIC 82485
7 GRAPHIC g772608g42a76.jpg GRAPHIC 24406
  Complete submission text file 0001193125-19-194786.txt   593139
Mailing Address 60 AVENUE ROCKEFELLER BATIMENT ADENINE LYON I0 69008
Business Address 60 AVENUE ROCKEFELLER BATIMENT ADENINE LYON I0 69008 011-33-4-78-74-44-38
Erytech Pharma S.A. (Filer) CIK: 0001624422 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-232669 | Film No.: 19957386
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences